Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
1,084 results
  • New medical therapies on the horizon: oral octreotide. [Review]
  • PPituitary 2017 Jan 16
  • Biermasz NR
  • Somatostatin analog treatment is first line medical treatment in patients with acromegaly. This drug is currently mainly administered by monthly depot preparations of octreotide and lanreotide. With ...
  • Adipsic diabetes insipidus in adult patients. [Review]
  • PPituitary 2017 Jan 10
  • Cuesta M, Hannon MJ, Thompson CJ
  • CONCLUSIONS: The management of ADI is challenging and is associated with significant morbidity and mortality. Prognosis is variable; hypothalamic complications lead to early death in some patients, but recent reports highlight the possibility of recovery of thirst.
  • Cabergoline in acromegaly. [Review]
  • PPituitary 2016 Dec 26
  • Kuhn E, Chanson P
  • Acromegaly, a rare disease due to growth hormone (GH) hypersecretion by a pituitary adenoma, is associated with severe comorbidity and premature death if not adequately treated. The usual first-line ...
  • Benzene and 2-ethyl-phthalate induce proliferation in normal rat pituitary cells. [Journal Article]
  • PPituitary 2016 Nov 16
  • Tapella L, Sesta A, … Pecori Giraldi F
  • CONCLUSIONS: Our findings indicate that benzene and 2-ethyl-phthalate activate AhR/AIP expression and stimulate proliferation in normal rat pituitary cells. This study is the first demonstration that pollutants can induce normal pituitary cells to proliferate and provides a link between epidemiological and genomic findings in pituitary tumors.
New Search Next